Skip to content
TrialScanner

NCT04433585

A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)

Phase 2CompletedNKTRLeadLLYCollaborator

Registry record

Lead sponsor
Nektar Therapeutics
Conditions
Systemic Lupus Erythematosus
Primary completion
Jan 10, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04433585 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04433585: A Study of LY3471851 in... | TrialScanner